{"id":250998,"date":"2022-04-05T00:00:00","date_gmt":"2022-04-05T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/epidim0024-biopharma-psoriatic-arthritis-epidemiology-mature\/"},"modified":"2026-04-21T11:21:43","modified_gmt":"2026-04-21T11:21:43","slug":"epidim0024-biopharma-psoriatic-arthritis-epidemiology-mature-markets","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidim0024-biopharma-psoriatic-arthritis-epidemiology-mature-markets\/","title":{"rendered":"Psoriatic Arthritis &#8211; Epidemiology &#8211; Mature Markets"},"content":{"rendered":"<p>Clarivate Epidemiology&#8217;s coverage of psoriatic arthritis (<abbr title=\"psoriatic arthritis\">PsA<\/abbr>) comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of <abbr title=\"psoriatic arthritis\">PsA<\/abbr> for each country, as well as annualized case counts projected to the national population.<\/p>\n<p>Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets of the United States, Europe, and Japan, and 10 years for the other countries covered in this report.<\/p>\n<p>Clarivate Epidemiology&#8217;s <abbr title=\"psoriatic arthritis\">PsA<\/abbr> forecast will answer the following questions:<\/p>\n<ul class=\"round-bullets\">\n<li>Of all people with <abbr title=\"psoriatic arthritis\">PsA<\/abbr>, how many in each country across the major mature pharmaceutical markets have been formally diagnosed?<\/li>\n<li>Of all people diagnosed with <abbr title=\"psoriatic arthritis\">PsA<\/abbr>, how many in each country across the major mature pharmaceutical markets are drug-treated?<\/li>\n<li>How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of <abbr title=\"psoriatic arthritis\">PsA<\/abbr> over the forecast period?<\/li>\n<\/ul>\n<p>All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to <abbr title=\"multiple sclerosis\">MS<\/abbr> Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.<\/p>\n<p>In total, Clarivate Epidemiology forecasts six <abbr title=\"psoriatic arthritis\">PsA<\/abbr> patient populations, as follows:<\/p>\n<ul class=\"round-bullets\">\n<li>Total <abbr title=\"psoriatic arthritis\">PsA<\/abbr> prevalent cases.<\/li>\n<li>Diagnosed <abbr title=\"psoriatic arthritis\">PsA<\/abbr> prevalent cases.<\/li>\n<li>Diagnosed <abbr title=\"psoriatic arthritis\">PsA<\/abbr> drug-treated prevalent cases.<\/li>\n<li>Diagnosed PsA prevalent cases with peripheral joint involvement.<\/li>\n<li>Diagnosed <abbr title=\"psoriatic arthritis\">PsA<\/abbr> prevalent cases with axial joint involvement.<\/li>\n<li>Diagnosed <abbr title=\"psoriatic arthritis\">PsA<\/abbr> prevalent cases with mixed joint involvement.<\/li>\n<\/ul>\n<p>Note: Coverage may vary by country.<\/p>\n","protected":false},"template":"","class_list":["post-250998","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-psoriatic-arthritis","biopharma-therapy-areas-rheumatology","biopharma-product-epidemiology","biopharma-date-960"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/250998","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/250998\/revisions"}],"predecessor-version":[{"id":283442,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/250998\/revisions\/283442"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=250998"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}